Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this...
process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(75)
•••
db2067
X
View Profile
View Bullboard History
Post by
db2067
on Jul 04, 2022 9:44am
Patent
Satellos Co-founder and CSO, Dr. Michael Rudnicki, a co-inventor, noted, "this new patent application represents the culmination of two years of imaginative and detailed scientific effort led by
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 29, 2022 6:21pm
New Press Release - Satellos Bioscience Announces In-Licensing of New Patent Application
Toronto, Ontario--(Newsfile Corp. - June 29, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that it has licensed a...
read article.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 22, 2022 7:01am
New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Officially Recognized as a Fellow of the Royal Society
Toronto, Ontario--(Newsfile Corp. - June 22, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Corporation"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that Co-founder and...
read article.
(6)
•••
sovy888
X
View Profile
View Bullboard History
Comment by
sovy888
on Jun 21, 2022 8:40pm
RE:RE:Down again
you're absolutely right... this looks more and more like a big time loser
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 17, 2022 7:02am
New Press Release - Satellos Bioscience Co-Founder and Chief Scientific Officer Awarded Prestigious Defeat Duchenne Canada 2022 Grant
Toronto, Ontario--(Newsfile Corp. - June 17, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, announced today that Co-founder and Chief...
read article.
(9)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Jun 16, 2022 6:36pm
RE:Down again
and again..investors just wanting out at this point.. kicking myself for not exiting when we had that last bump to 1.20. It really seems like satellos has nothing going on other than hopes and dreams.
...more
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 14, 2022 7:15pm
Down again
Down .02 on volume guess we don't need your update Frankie boy! Waste of time and money Frankie boy hope you got lucky and shipfaced, least us shareholders could do for you. Lol
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 10, 2022 6:31pm
LD Micro Invatational
Hey Frankie boy did you enjoy your paid vacation at your June 7 [ that was 3 days ago and we the shareholders have heard nothing? ] presentation? CAN HARDLY WAIT TO HEAR ALL THE GOOD
...more
(9)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Jun 08, 2022 4:05pm
RE:.0325
absolutely brutal.. "nasdaq listing this year" laughable... don't worry I'm sure there will be some more big news about another conference they are going to.
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 06, 2022 6:23pm
.0325
Pre-consolidation price nice job BND over and management bonuses all around. You guys all should be in jail.
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Jun 06, 2022 6:13pm
Hey “BND” overt
.65 you still collecting your $10,000 a month? What a fn joke this company and directors are.
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on May 09, 2022 2:03pm
MSCL Hiccup .85
LOL
(29)
•••
flight100
X
View Profile
View Bullboard History
Post by
flight100
on Apr 08, 2022 12:10pm
MSCL HUP 1.10
eom
(30)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Mar 14, 2022 2:04pm
Sleeping pills
So if I'm correct in a year from now we may have a "cbd" based sleeping pill. Hopefully I won't lose any sleep waiting for this leading edge technology LOL WAFJ.
(306)
•••
beenthere
X
View Profile
View Bullboard History
Post by
beenthere
on Mar 12, 2022 9:14am
Some Hope?
Satellos Bioscience Provides Update on Joint Development Initiative with NW PharmaTech Limited NewsfileMar 11, 2022 7:00 AM EST
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >